logo

For the Inventor, By the Inventor

Harlow, United Kingdom

Emanuela Gancia

This inventor holds 18 USPTO granted patents and 6 published patent applications and 13 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Genentech, Inc., Charles River Laboratories, Inc.. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Emanuela Gancia. Retrieved from https://idiyas.com/inventor/emanuela-gancia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18 

% Patents Active = 66.7

 

Average Co-Inventor Count = 10.5

ph-index = 3

Forward Citations = 46(Granted Patents)


Location History:

  • Harlow Essex, GB (2013)
  • Essex, GB (2019 - 2021)
  • Harlow, GB (2013 - 2024)

Company Filing History:

goldMedal17 out of 3,304 
 
Genentech, Inc.
 patents
silverMedal1 out of 52 
 
Charles River Laboratories, Inc.
 patents

Years Active: 2013-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Isoquinoline Compounds
Naphthyridine Compounds
Aza-Heterocyclyl Carboxamide
Spirocyclic Compounds
HPK1 Inhibitors
RORc Modulators
Azaindoles
Pyridazine Derivatives
Benzoxazepin Compounds
MEK Kinase Inhibitors
Aryl Sultam Derivatives
Diazacarbazoles
18 patents (USPTO):Explore Patents
1. 12378249 - Isoquinoline compounds and uses thereof (2025-08-05),
2. 12297210 - Naphthyridine compounds and uses thereof (2025-05-13),
3. 12227475 - Aza-heterocyclyl carboxamide and related compounds and their use in treating medical conditions (2025-02-18),
4. 12208088 - Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereof (2025-01-28),
5. 11944606 - Azaindoles as inhibitors of HPK1 (2024-04-02),
6. 11566003 - Isoquinolines as inhibitors of HPK1 (2023-01-31),
7. 11034692 - Naphthyridines as inhibitors of HPK1 (2021-06-15),
8. 11008312 - Pyridazine derivatives as RORc modulators (2021-05-18),
9. 10952995 - Azaindoles as inhibitors of HPK1 (2021-03-23),
10. 10407424 - Naphthyridines as inhibitors of HPK1 (2019-09-10),
11. 10280144 - Pyridazine derivatives as RORc modulators (2019-05-07),
12. 10259808 - Aryl sultam derivatives as RORc modulators (2019-04-16),
13. 10131644 - Aryl sultam derivatives as RORc modulators (2018-11-20),
14. 9751873 - Aryl sultam derivatives as RORc modulators (2017-09-05),
15. 9216980 - Methods of use of diazacarbazoles for treating cancer (2015-12-22),

Title: The Innovative Journey of Emanuela Gancia

Introduction: Emanuela Gancia, a pioneering inventor hailing from Harlow, GB, has made significant contributions to the world of technology and innovation.

Latest Patents: Emanuela Gancia's latest patents focus on sustainable energy solutions and advanced medical devices, showcasing her versatility and forward-thinking approach.

Career Highlights: Throughout her illustrious career, Emanuela Gancia has been recognized for her groundbreaking work in various fields, including artificial intelligence, renewable energy, and biotechnology.

Collaborations: Emanuela Gancia has collaborated with leading research institutions, universities, and tech companies to bring her innovative ideas to life, fostering a culture of creativity and progress.

Conclusion: Emanuela Gancia's passion for innovation and her relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…